Edition:
United States

Zhongyuan Union Cell & Gene Engineering Corp Ltd (600645.SS)

600645.SS on Shanghai Stock Exchange

26.80CNY
--
Change (% chg)

-- (--)
Prev Close
¥26.80
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,717,713
52-wk High
¥44.44
52-wk Low
¥26.79

Latest Key Developments (Source: Significant Developments)

Zhongyuan Union Cell&Gene Engineering to buy 28 pct share in Shenzhen-based investment LP
Monday, 27 Mar 2017 01:51am EDT 

Zhongyuan Union Cell & Gene Engineering Corp Ltd <600645.SS> : Says it will buy 28 percent share in a Shenzhen-based investment limited partnership from a bio-tech company . Transaction amount is 17.8 million yuan for the 21 million yuan worth of actual capital contribution in the first phase .It will invest additional 49 million yuan as capital contribution according to partnership agreement, for the second phase.  Full Article

Zhongyuan Union Cell & Gene Engineering plans to acquire genetic research firm
Wednesday, 22 Feb 2017 06:00am EST 

Zhongyuan Union Cell & Gene Engineering Corp Ltd <600645.SS> :Says it plans to acquire an investment management firm which owns genetic research firm OriGene Technologies Inc in the U.S..  Full Article

Zhongyuan Union Cell & Gene Engineering unit sells 38 pct stake in genetic engineering firm at 45 mln yuan
Thursday, 12 Jan 2017 02:30am EST 

Zhongyuan Union Cell & Gene Engineering Corp Ltd <600645.SS>:Says its unit Union Stemcell & Gene Engineering Co Ltd sold 38 percent stake in Tianjin Amcellgene Engineering Co Ltd to a Beijing-based biotechnology company at price of 45 million yuan.  Full Article

Zhongyuan Union Cell to acquire stake in Eastern Union Stem Cell for 128.3 mln yuan
Friday, 30 Dec 2016 02:00am EST 

Zhongyuan Union Cell & Gene Engineering Corp Ltd <600645.SS> :Says it plans to buy 52.6 percent stake in Eastern Union Stem Cell & Gene Engineering for 128.3 million yuan ($18.46 million).  Full Article

Zhongyuan Union Cell and Gene Engineering unit to sell 38 pct stake in Tianjin Amcellgene Engineering Co Ltd at 45 mln yuan
Tuesday, 27 Dec 2016 04:31am EST 

Zhongyuan Union Cell and Gene Engineering <600645.SS>: Says its subsidiary Union Stemcell & Gene Engineering Co Ltd will sell 38 percent stake in Tianjin Amcellgene Engineering Co Ltd to a Beijing-based biotechnology company .Says Union Stemcell & Gene Engineering Co Ltd holds 38 percent stake in Tianjin Amcellgene Engineering Co Ltd now.  Full Article

Zhongyuan Union Cell & Gene Engineering to establish unit
Tuesday, 30 Aug 2016 02:59am EDT 

Zhongyuan Union Cell & Gene Engineering Corp Ltd <600645.SS> : Says it will establish a wholly owned subsidiary, with a registered capital of 30 million yuan .The new subsidiary will be mainly engaged in adult cell tissue storage, biotechnology development and cellular genetic engineering industrialization businesses.  Full Article

Zhongyuan Union Cell & Gene Engineering to invest 10 mln yuan to set up unit
Monday, 9 May 2016 11:57pm EDT 

Zhongyuan Union Cell and Gene Engineering <600645.SS> : Says it to invest 10 million yuan establishing a new unit in Guangdong Province, with an investment management firm . Says the unit has a registered capital of 12 million yuan, and will be engaged in the development of biotechnology .Says company to hold 83.3 percent stake in the unit.  Full Article

Zhongyuan Union Cell & Gene Engineering says Top Gene boosts unit capital to 10.3 mln yuan
Monday, 9 May 2016 11:45pm EDT 

Zhongyuan Union Cell and Gene Engineering <600645.SS> : Says Top Gene to inject capital of 20 mln yuan in company's sub-unit, a Tianjin-based research institute, to acquire 3.2 pct stake in target co. .Says the unit's registered capital to expand to 10.3 million yuan.  Full Article

ZHONGYUAN UNION CELL & GENE ENGINEERING announces no dividend payment for 2015
Friday, 29 Apr 2016 08:00pm EDT 

ZHONGYUAN UNION CELL & GENE ENGINEERING CORP., LTD:Says no dividend payment for 2015.  Full Article

ZHONGYUAN UNION CELL & GENE ENGINEERING to establish new subsidiary in United States
Monday, 11 Apr 2016 08:00pm EDT 

ZHONGYUAN UNION CELL & GENE ENGINEERING CORP., LTD:To establish a wholly owned subsidiary in the United States, namely VcanBio Center for Translational Biotechnology Corp.The new subsidiary with a registered capital of $5 mln.  Full Article

More From Around the Web